Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith T Zemanick

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.
BMC Microbiology|October 27, 2023
Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infectionBrandie D Wagner, Edith T Zemanick, Scott D Sagel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2023
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screenJ Kirk Harris, Brandie D Wagner, Charles E Robertson, et al.
Thorax|November 18, 2016
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trialMarianne Sponer Muhlebach, Valeria Beckett, Elena Popowitch, et al.
Heliyon|June 10, 2020
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulationAndrea Hahn, Aszia Burrell, Emily Ansusinha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 18, 2017
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTRScott H Donaldson, George M Solomon, Pamela L Zeitlin, et al.
Scientific Reports|February 24, 2019
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosisAndrea Hahn, Hani Fanous, Caroline Jensen, et al.
Pediatric Pulmonology|January 21, 2025
C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary ExacerbationsJonathan B Zuckerman, Alexandra C Hinton, Thomas Lahiri, et al.
Annals of the American Thoracic Society|September 8, 2023
A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment StrategiesDon B Sanders, Traci M Bartz, Edith T Zemanick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 1, 2024
Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task forceJordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The European Respiratory Journal|February 19, 2026
Impact of CFTR Modulator Concentrations on Clinical Response in Cystic FibrosisAshritha R Chalamalla, Elizabeth Baker, Kevin J Ryan, et al.
BMC Microbiology|October 27, 2023
Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infectionBrandie D Wagner, Edith T Zemanick, Scott D Sagel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2023
Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screenJ Kirk Harris, Brandie D Wagner, Charles E Robertson, et al.
Thorax|November 18, 2016
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trialMarianne Sponer Muhlebach, Valeria Beckett, Elena Popowitch, et al.
Heliyon|June 10, 2020
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulationAndrea Hahn, Aszia Burrell, Emily Ansusinha, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 18, 2017
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTRScott H Donaldson, George M Solomon, Pamela L Zeitlin, et al.
Scientific Reports|February 24, 2019
Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosisAndrea Hahn, Hani Fanous, Caroline Jensen, et al.
Pediatric Pulmonology|January 21, 2025
C-Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary ExacerbationsJonathan B Zuckerman, Alexandra C Hinton, Thomas Lahiri, et al.
Annals of the American Thoracic Society|September 8, 2023
A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment StrategiesDon B Sanders, Traci M Bartz, Edith T Zemanick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 1, 2024
Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task forceJordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, et al.
Pageof 9